Medicure Inc
Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market in Canada and the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company offers ReDS, a non-invasive medical device that offers measurement of lung fluid for the management of congestive heart failure. Further, the company offers Sodium Nitroprusside injection for the reduction of blood pressure for adult and pediatric patients in hypertensive crisis, as well as for producing controlled hypotension to reduce bleeding during surgery, and for the treatment of acute congestive heart failure. It offers products through retail pharmacies, as well as online. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada. Show More...
-
Website https://www.medicure.com
-
Sector Healthcare
-
Industry Drug Manufacturers-Specialty & Generic
-
Last Quote 0.66 EUR
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-05 2011-05 2012-05 2013-05 2014-05 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share CAD -0.6 -0.15 1.99 -0.21 -0.16 0.11 1.56 2.39 0.24 -1.32 -1.28 Dividends CAD Payout Ratio % * Shares Mil 9.0 9.0 12.0 12.0 12.0 16.0 17.0 18.0 17.0 15.0 14.0 Book Value Per Share * EUR 0.09 0.47 0.88 3.46 4.67 1.64 Free Cash Flow Per Share * EUR 0.02 0.19 1.04 -0.14 -1.26 Return on Assets % -71.28 -36.14 471.6 -63.04 -46.62 12.0 23.44 25.27 3.37 -27.1 -26.15 Financial Leverage (Average) 4.76 5.82 1.6 1.24 1.57 1.6 Return on Equity % 606.11 133.84 73.86 4.78 -35.8 -34.77 Return on Invested Capital % 40.07 48.62 46.76 3.67 -36.26 -34.24 Interest Coverage -0.83 0.35 43.23 -5.16 -2.94 4.51 25.83 28.1 Current Ratio 0.05 0.06 1.6 0.42 0.71 1.69 0.91 2.62 5.29 2.69 2.57 Quick Ratio 0.02 0.03 1.12 0.16 0.39 1.29 0.48 2.21 4.88 1.99 1.78 Debt/Equity 0.59 1.86 0.03 0.03